About this trial
The study focuses on the impact of tooth loss on alveolar bone, which shrinks significantly within the first three months. To prevent this, strategies like alveolar ridge preservation are used.
Autogenous dentin, taken from the patient, supports healing and bone regrowth. Platelet-rich fibrin (PRF), made from the patient's blood, enhances healing and bone density by releasing growth factors.
A new technique combining L-PRF with albumin creates a stable healing membrane that provides a steady release of growth factors. Overall, these methods improve recovery after tooth extractions and prepare sites for future dental work.
Eligibility criteria
Qualifiers
Medically free patients.
Adult patients above 18 Years to 60 Years.
Non-restorable tooth indicated for extraction.
Posterior mandibular teeth.
Disqualifiers
Presence of any systemic disease that could influence the outcome of the therapy.
Presence of any risk factor (smoker, pregnant and lactating patients).
Patients with bone diseases.
Patients with poor oral hygiene.
Trial design
Treatments tested in this trial
- empty socket
- Autogenous Dentin Graft with Platelet Rich Fibrin
- Autogenous Dentin Graft with Albumin Platelet Rich Fibrin